Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Winnie H Wan
AddedMar 31, 2024
UpdatedMay 31, 2026
Winnie H Wan

Winnie H Wan

Board Member, Life Science Angels

CrunchbaseLinkedIn

Winnie H Wan's Career

Life Science Angels
Life Science Angels

Sunnyvale, CA, US

Board Member· Board
Kryptos Biotechnologies
Kryptos Biotechnologies

Hayward, CA, US

Board Member· Board
Saccharo
Saccharo

Oakland, CA, US

Board Member· Board
Chameleon Biosciences
Chameleon Biosciences

San Anselmo, CA, US

Board Member· Board
Inhalon Biopharma
Inhalon Biopharma

Durham, NC, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Winnie H Wan's Career

Life Science Angels
Life Science Angels
Investment FirmInvestment Firm1022004Sunnyvale, CA, US
Board Member· Board

Leadership at Life Science Angels

Allan MayAllan MayBoard Member
Partha RayPartha RayBoard Member
Casey McGlynnCasey McGlynnBoard Member
Faz BashiFaz BashiBoard Member
Laura DietchLaura DietchBoard Member
Lucy LuLucy LuBoard Member

Similar to Life Science Angels

Mass Medical AngelsMass Medical AngelsBoston, MA, USest. 2007Mass Medical AngelsBoston, MA, US · est. 2007

MA2: A US-based venture capital firm specializing in life science and healthcare investments.

Investment Firm175
Mid Atlantic Bio AngelsMid Atlantic Bio AngelsNew York City, NY, USest. 2012Mid Atlantic Bio AngelsNew York City, NY, US · est. 2012

MABA: A US-based venture capital firm specializing in life science investments.

Investment Firm38
Central Coast AngelsCentral Coast AngelsSanta Cruz, CA, USest. 2013Central Coast AngelsSanta Cruz, CA, US · est. 2013

Central Coast Angels: A California-based venture capital firm specializing in early-stage financing for agriculture, food, and life sciences sectors.

Investment Firm5
Synergy Life Science PartnerSynergy Life Science PartnerSan Francisco, CA, USest. 2006Synergy Life Science PartnerSan Francisco, CA, US · est. 2006

Synergy Life Science Partners: A California-based venture capital firm investing in early-stage medical companies.

Investment Firm6
Kryptos Biotechnologies
Kryptos Biotechnologies
Seed$5.3M52017Hayward, CA, US
Board Member· Board

Leadership at Kryptos Biotechnologies

Jinyong LeeJinyong LeeCo-Founder
Jun Ho SonJun Ho SonCo-Founder

Similar to Kryptos Biotechnologies

Cryptyx BioscienceCryptyx BiosciencePrinceton, NJ, USDrug Discoveryest. 2020Cryptyx BiosciencePrinceton, NJ, US · est. 2020

Cryptyx Bioscience: A biopharmaceutical platform unlocking therapeutic potential in bacteria.

Angel · $256k1
Prompt DiagnosticsPrompt DiagnosticsBaltimore, MD, USDiagnostic TestsPrompt DiagnosticsBaltimore, MD, US

Prompt Diagnostics: Rapid, affordable, and precise biotech firm for easy-to-use diagnostic testing.

Pre-Seed · $600k2
ZymeronZymeronDurham, NC, USHealthcareest. 2016ZymeronDurham, NC, US · est. 2016

Zymeron: A research-driven biotech firm innovating in healthcare tech for disease detection, prevention, and treatment.

Public · $75k13
KariusKariusRedwood City, CA, USDiagnostics, Testingest. 2014KariusRedwood City, CA, US · est. 2014

Karius, Inc.: A life science firm revolutionizing infectious disease diagnostics with advanced testing in the US.

Series B · $254M187
Saccharo
Saccharo
Series A$7.4M42017Oakland, CA, US
Board Member· Board

Leadership at Saccharo

Sherry Martin-MoeSherry Martin-MoeCo-Founder
Gregory MoeGregory MoeCo-Founder

Similar to Saccharo

GlycyxGlycyxSan Francisco, CA, USCancer Therapiesest. 2020GlycyxSan Francisco, CA, US · est. 2020

Glycyx: Innovating minimally-toxic cancer therapies to enhance immune response and reduce tumor growth.

Series A · $3.6M7
ShasqiShasqiSan Francisco, CA, USCancer Therapeuticsest. 2015ShasqiSan Francisco, CA, US · est. 2015

Shasqi: Innovating cancer treatment with click chemistry for targeted therapy.

Seed · $65.4M24
GlycologixGlycologixBeverly, MA, USBiomaterials, Therapiesest. 2016GlycologixBeverly, MA, US · est. 2016

Glycologix: A biotech firm specializing in R&D for soft tissue protection and repair.

Pre-Seed · $2.9M6
CancervaxCancervaxSanta Barbara, CA, USCancer Treatmentest. 2021CancervaxSanta Barbara, CA, US · est. 2021

CancerVAX Biotech: Santa Barbara-based medical firm innovating universal cancer treatments.

Seed · $500k13
Chameleon Biosciences
Chameleon Biosciences
Seed$14.2M122017San Anselmo, CA, US
Board Member· Board

Leadership at Chameleon Biosciences

Jeffery VickJeffery VickCo-Founder
Genine WinslowGenine WinslowBoard Member
Inhalon Biopharma
Inhalon Biopharma
Seed$11.9M112018Durham, NC, US
Board Member· Board

Leadership at Inhalon Biopharma

Sam LaiSam LaiFounder
John WhelanJohn WhelanCEO

Similar to Inhalon Biopharma

Alveolus BioAlveolus BioBirmingham, AL, USBiotherapeuticsest. 2020Alveolus BioBirmingham, AL, US · est. 2020

Alveolus Bio: Innovating FDA-approved therapeutics for lung diseases.

Series A · $7M7
Aer TherapeuticsAer TherapeuticsRaleigh, NC, USBiopharmaceuticalsest. 2014Aer TherapeuticsRaleigh, NC, US · est. 2014

Aer Therapeutics: Clinical-stage biopharma developing treatments for severe respiratory diseases.

Series A · $36M12
Transpire BioTranspire BioWeston, FL, USInhaled Medicinesest. 2022Transpire BioWeston, FL, US · est. 2022

Transire Bio: Innovating painless delivery of injectable drugs through inhaled medicine development.

Angel · $10k30
Halia TherapeuticsHalia TherapeuticsSalt Lake City, UT, USTherapeuticsest. 2017Halia TherapeuticsSalt Lake City, UT, US · est. 2017

Halia Therapeutics: Preclinical biopharma firm innovating therapies for inflammatory and neurological disorders.

Series C · $47.2M11

Winnie H Wan's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Winnie H Wan

Frank WillemsenFrank WillemsenBoard Member · Sand Hill AngelsMichael YangMichael YangBoard Member · Kiwi CratePeter HenigPeter HenigBoard Member · Linkage BiosciencesMark TaylorMark TaylorBoard Member · Alliance of AngelsScott DavisScott DavisBoard Member · Frontier AngelsChris AdelsbachChris AdelsbachBoard Member · Crowdz